Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist device implantation

Annals of Thoracic Surgery

Volumn 96, Issue 6, 2013, Pages 2161-2167

  Stulak, John M ^a   Deo, Salil ^a   Schirger, John ^a   Aaronson, Keith D ^b   Park, Soon J ^a   Joyce, Lyle D ^a   Daly, Richard C ^a   Pagani, Francis D ^b  

^a Mayo Clinic   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CEREBROVASCULAR ACCIDENT; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEART RIGHT VENTRICLE FAILURE; HEMOLYSIS; HUMAN; IMPLANTATION; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PREOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK FACTOR; THROMBOEMBOLISM; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; ADOLESCENT; COMPARATIVE STUDY; COMPLICATION; FOLLOW UP; HEART ASSIST DEVICE; HEART FAILURE; INCIDENCE; MIDDLE AGED; PATHOPHYSIOLOGY; PREOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TRENDS; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ATRIAL FIBRILLATION; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; INCIDENCE; MALE; MICHIGAN; MIDDLE AGED; PREOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; THROMBOEMBOLISM; YOUNG ADULT;

EID: 84889248873     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2013.07.004     Document Type: Article

References (20)

1. D.M. Lloyd-Jones, T.J. Wang, and Leip Lifetime risk for development of atrial fibrillation: the Framingham Heart Study Circulation 110 2004 1042 1046
2. W.G. Stevenson, L.W. Stevenson, and H.R. Middlekauf Improving survival for patients with atrial fibrillation and advanced heart failure J Am Coll Cardiol 28 1996 1458 1463
3. J.K. Kirklin, D.C. Naftel, and R.L. Kormos Third INTERMACS annual report: the evolution of destination therapy in the United States J Heart Lung Transplant 30 2011 115 123
4. J.K. Kirklin, D.C. Naftel, and R.L. Kormos The fourth INTERMACS annual report: 4,000 implants and counting J Heart Lung Transplant 31 2012 117 126
5. J.K. Kirklin, D.C. Naftel, and F.D. Pagani Long-term mechanical circulatory support (destination therapy): On track to compete with heart transplantation? J Thorac Cardiovasc Surg 144 2012 584 603
6. N. Yuan, G.J. Arnaoutakis, and T.J. George The spectrum of complications following left ventricular assist device placement J Card Surg 27 2012 630 638
7. D. Backes, W.M. van den Bergh, A.L. van Dujin, J.R. Lahpor, and A.J. Slooter Cerebrovascular complications of left ventricular assist devices Eur J Cardiothorac Surg 42 2012 612 620
8. I. Nakajima, T.S. Kato, and K. Komamura Pre- and post-operative risk factors associated with cerebrovascular accidents in patients supported by left ventricular assist device. Single center's experience in Japan Circ J 75 2011 1138 1146
9. T.S. Kato, P.C. Schulze, and J. Yang Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device J Heart Lung Transplant 31 2012 1 8
10. M. Rossi, G.F. Serraino, F. Jiritano, and A. Renzulli What is the optimal anticoagulation in patients with a left ventricular assist device? Interact Cardiovasc Thorac Surg 15 2012 733 740
11. R. John, S. Panch, and J. Hrabe Activation of endothelial and coagulation systems in left ventricular assist device recipients Ann Thorac Surg 88 2009 1171 1179
12. E.J. Benjamin, P.A. Wolf, R.B. D'Agostino, H. Silbershatz, W.B. Kannel, and D. Levy Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 1998 946 952
13. T.R. Graham, K. Dasse, and A. Coumbe Neo-intimal development on textured biomaterial surfaces during clinical use of an implantable left ventricular assist device Eur J Cardiothorac Surg 4 1990 182 190
14. A.K. Menon, A. Gotzenich, H. Sassmannshausen, M. Haushofer, R. Autschback, and J.W. Spillner Low stroke rate and few thromboembolic events after HeartMate II implantation under mild anticoagulation Eur J Cardiothorac Surg 42 2012 319 323
15. A.J. Boyle, S.D. Russel, and J.J. Teuteberg Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anticoagulation J Heart Lung Transplant 28 2009 881 887
16. R. John, F. Kamdar, and K. Liao Low thromboembolic risk for patients with the HeartMate II left ventricular assist device J Thorac Cardiovasc Surg 136 2008 1318 1323
17. N.L. Pereira, D. Chen, S.S. Kushwaofanha, and S.J. Park Discontinuation of antithrombotic therapy for a year or more in patients with continuous flow left ventricular assist devices Interact Cardiovasc Thorac Surg 11 2010 503 505
18. H.S. Lim, S.R. Willoughby, and C. Schultz Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm J Am Coll Cardiol 61 2013 852 860
19. R.L. Ranganathan, and P. Venkatesh Atrial fibrillation and stroke prevention: is warfarin still an option? -No J Neural Transm 2012 Dec 14 [Epub ahead of print]
20. J.S. Kwong, Y.Y. Lam, B.P. Yan, and C.M. Yu Bleeding of new oral anticoagulants for stroke prevention in atrial fibrillation: a meta-analysis of randomized controlled trials Cardiovasc Drugs Ther 27 2013 23 35